Home › Trial NCT02481726
68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT
- Trial IDNCT02481726
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorXijing Hospital
- Enrollment31
- Start date2014-03
- ConditionsLung Cancer · Lung Tuberculosis
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.